Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities
- 24 January 2025
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 286, 117314
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluationsChinese Chemical Letters, 2024
- Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategiesMedComm – Oncology, 2023
- Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018–2021)Acta Pharmaceutica Sinica B, 2022
- Expedition of sulfur‐containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade updateMedicinal Research Reviews, 2021
- Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancerCancer Letters, 2020
- Medicinal chemistry of indole derivatives: Current to future therapeutic prospectivesBioorganic Chemistry, 2019
- Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solutionCancer Letters, 2019
- Aminochrome Toxicity is Mediated by Inhibition of Microtubules Polymerization Through the Formation of Adducts with TubulinNeurotoxicity Research, 2015
- 3-(3,4,5-Trimethoxyphenylselenyl)-1H-indoles and their selenoxides as combretastatin A-4 analogs: Microwave-assisted synthesis and biological evaluationEuropean Journal of Medicinal Chemistry, 2015
- Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducersBioorganic & Medicinal Chemistry Letters, 2009